Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
Saved in:
| Title: | Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. |
|---|---|
| Authors: | Brahmer, Julie1 brahmju@jhmi.edu, Reckamp, Karen L.2, Baas, Paul3, Crinò, Lucio4, Eberhardt, Wilfried E. E.5,6, Poddubskaya, Elena7, Antonia, Scott8, Pluzanski, Adam9, Vokes, Everett E.10, Holgado, Esther11, Waterhouse, David12, Ready, Neal13, Gainor, Justin14, Frontera, Osvaldo Arén15, Havel, Libor16, Steins, Martin17, Garassino, Marina C.18, Aerts, Joachim G.19, Domine, Manuel20, Paz-Ares, Luis21 |
| Source: | New England Journal of Medicine. 7/9/2015, Vol. 373 Issue 2, p123-135. 13p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!